Clinical Trials in the Category "Liver Neoplasms"
Device Intervention Trials that are Recruiting
Study Title |
Principal Investigator | Disease Category | |
|
|||
| Impact of C-arm CT in patients with HCC undergoing TACE: Optimal Imaging Guidance |
Dr. Rebecca Fahrig Nishita N. Kothary |
Carcinoma, Hepatocellular | |
|
|||
Other Trials that are Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
| Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors |
Paul J Keall Amit Sawant |
Pancreatic Cancer
Liver Cancer Lung Cancer | |
|
|||
Trials not Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
|
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
(Terminated) |
Samuel So |
Carcinoma, Hepatocellular | |
|
|||
|
Microarray Analysis of Gene Expression in Liver Tumors
(Completed) |
Samuel So |
Liver Cancer | |
|
|||
|
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
(Completed) |
Albert Koong |
Cholangiocarcinoma
Liver Cancer Adenocarcinoma | |
|
|||
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |
Trial Administration